Global Novel Drug Delivery Systems Market Worth $171.02 Billion by 2029, Growing at 9.8% CAGR

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Novel Drug Delivery Systems Market Outlook: What Size And CAGR Are Anticipated By 2025?
There has been a swift growth in the market size of novel drug delivery systems in the past few years. The market will expand from $106.95 billion in 2024 to $117.66 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.0%. Several factors like the increasing incidence of chronic illnesses, a bulging geriatric population, surging demand for minimally invasive treatments, heightened patient consciousness about the effectiveness and safety of drugs, and the development of the worldwide healthcare infrastructure, explain the growth during this historical period.

What Is the Expected CAGR for the Novel Drug Delivery Systems Market Growth Through 2029?
The market for novel drug delivery systems is anticipated to witness robust growth in the coming years. The market is projected to reach $171.02 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this predicted growth over the forecast period include the growing global attention towards pandemic readiness, the escalating demand for prompt and localized drug delivery, increasing awareness of antimicrobial stewardship, stricter environmental and packaging guidelines that support controlled delivery formats, and the surge in public-private collaborations for pharmaceutical innovation. Key trends to watch during the forecast period include the incorporation of nanocarriers and nanoemulsions, the creation of biodegradable and stimuli-responsive materials, greater use of 3D printing for personalized dosage forms, progress in transdermal and microneedle systems, and the embracing of artificial intelligence in formulating design.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/novel-drug-delivery-systems-global-market-report

What Are the Primary Drivers Behind Novel Drug Delivery Systems Market Growth?
The rising neurological disorder cases are expected to propel the growth in the novel drug delivery systems market going forward. A neurological disorder such as stroke is a medical condition characterized by the sudden loss of neurological function due to an interruption in blood supply to the brain, either through blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke), leading to brain tissue damage and potentially long-term cognitive, sensory, or motor impairments. The increasing incidence of neurological disorders is primarily driven by factors such as aging populations, increased prevalence of lifestyle-related conditions such as hypertension, diabetes, and obesity, and heightened exposure to chronic stress and environmental risk factors. Novel drug delivery systems help manage neurological disorders by enabling targeted and controlled delivery of therapeutics across the blood-brain barrier. For instance, in November 2024, according to the National Health Service (NHS) England, a UK-based healthcare system, stroke admissions in England rose to 111,137 in 2023/24, with the 50-59 age group recording the highest increase at 12,533 cases. Therefore, the rising neurological disorder cases are driving the growth of the novel drug delivery systems market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25850&type=smp

What Are the Key Segments Driving Novel Drug Delivery Systems Market Growth?
The novel drug delivery systems market covered in this report is segmented -

1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems
3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes
4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases
5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users

Subsegments:
1) By Liposomes: PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes
2) By Nanoparticles: Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals
3) By Microspheres: Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres
4) By Hydrogels: Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels
5) By Dendrimers: PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers

What Are the Technological Trends Impacting the Novel Drug Delivery Systems Market?
Key players in the novel drug delivery systems market, such as CD Formulation, are innovating with strategies like oral thin films to improve patient compliance and the effectiveness of therapy. Oral thin films are a style of medication delivery where a quickly dissolving. film strip is inserted into the mouth, designed to administer the medication directly into the bloodstream via the mucosal membrane. In February 2024, US-based company, CD Formulation introduced its Oral Thin Film Technology. The product is designed for quicker drug absorption by skipping digestion and liver metabolism, which can be particularly beneficial for those who struggle swallowing. Furthermore, it allows for precise dosage and quicker reaction time, enhancing the exactness and convenience of treatment across a range of therapeutic applications.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25850&type=smp

Who Are the Major Competitors in the Global Novel Drug Delivery Systems Market?
Major companies operating in the novel drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited.

Which Region Dominates the Novel Drug Delivery Systems Market Share in 2025?
North America was the largest region in the novel drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.